Elekta

Share Issue/Capital Change • Sep 28, 2007

NUMBER OF SHARES IN ELEKTA AS OF SEPTEMBER 28, 2007

PRESS RELEASE

Stockholm, Sweden, September 28, 2007

According to new legislation, all publicly listed companies must – if the number of shares has changed during the month – publish the total number of shares in the company on the last trading day of the month.

During August, 27,072 new B shares were issued in Elekta through the exercise of warrants distributed within the framework of the established option program.

The total number of shares in Elekta as of September 28, 2007 amounts to 93,880,090 divided between 3,562,500 A shares and 90,317,590 B shares.

Elekta's current holding of shares (treasury stock) amounts to 1,630,871 B shares, which the AGM on September 25 decided to cancel.

One Series A share entitles the holder to 10 votes and one Series B share to one vote.

******

For further information, please contact:

Okee Williams, Corporate Communications, Elekta AB Tel: +46 706 00 53 64 (mobile), e-mail: okee.williams@elekta.com

About Elekta

Elekta is an international medical-technology Group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta's solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective.

Clinical solutions include among others Leksell Gamma Knife® for non-invasive treatment of brain disorders and Elekta Synergy® for image guided radiation therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April 2005, the Elekta Group is the world's largest supplier of oncology software.

Elekta's systems and solutions are used at over 4,500 hospitals around the world to treat cancer and manage clinical operations as well as to diagnose and treat brain disorders, including tumors, vascular malformations and functional disorders.

With approx. 2,000 employees, Elekta's corporate headquarter is located in Stockholm, Sweden and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.